Scheme 3. Preparation of 2-Chloro-6-aminopyridines
Scheme 4. Synthesis of 7-Azaindolines and
Tetrahydro[1,8]naphthyridines
as pertains their antiinflammatory properties.10 However, it
is a somewhat inaccessible class of derivatives. Recently, a
free-radical-mediated aryl amination has been described
whereby an aryl radical, generated by tributyltin hydride,
adds to the nitrogen of an azomethine bond to give an
azaindoline.11 A second approach involving a directed ortho-
metalation of aminopyridines has been described to access
annulated pyridines derivatives.12
We have found that xanthate chemistry allows an expedi-
ent and especially versatile radical synthesis of azaindolines.
The method employs cheap, nontoxic, and easy to handle
compounds. Thus, treatment of 2,6-dichloropyridine with an
excess of allylamine produced in a quantitative yield the
2-allylamino-6-chloropyridine, which was protected by an
acetyl group before being subjected to the radical steps
(Scheme 3). Indeed, an addition-cyclization sequence using
xanthate derivatives provided the desired 7-azaindolines in
good yield (Scheme 4).
of great pharmaceutical importance,16 for instance, since
several drugs possess this backbone. Yet, very few proce-
dures have been reported for the synthesis of such com-
pounds. The usual route involves a regioselective hydroge-
nation of naphthyridines which are prepared via a Skraup17
or a Friedla¨nder reaction.18 An optimized intramolecular
Chichibabin reaction was also applied to access these bicyclic
heterocycles.19
In our case, all we had to do was to add one more carbon
to the side chain. Thus, 2-homoallylamino-6-chloropyridine
(7, n ) 2) was prepared in good yield by reacting 2,6-
dichloropyridine with excess 3-butenylamine in a sealed tube
at 140 °C. The addition of S-cyanomethyl-O-ethyl xanthate
gave an excellent yield of the corresponding adduct 9f (97%),
which underwent a smooth ring closure upon exposure to
stoichiometric amounts of lauroyl peroxide providing the
expected tetrahydronaphthyridine 10f in 72% yield. The
synthesis of 10g represents another example.
The tremendous flexibility of this approach is demon-
strated by the variety of the xanthates 8 that can be used
(examples 10a-e in Scheme 4). Furthermore, the oxazoli-
dinone derivative 10c can give rise to a wide library of
amides when treated with various amines.13 Compound 10b
is also of great interest since can be involved in a Hantzsch-
type14 reaction to form thiazole derivatives, which are known
as bioisosteres of pyridine rings. Its chlorine atom can also
be substituted by a xanthate group and engaged in a new
radical addition onto another olefinic trap.15
The unique advantages of the xanthate technology can be
appreciated in connection with the preparation of larger fused
rings. 1,2,3,4-Tetrahydro[1,8]naphthyridine derivatives are
(9) (a) Desarbre, E.; Me´rour, J.-Y. Tetrahedron Lett. 1996, 37, 43. (b)
Taylor, E. C.; Pont, J. L. Tetrahedron Lett. 1987, 28, 379.(c) Beattie, D.
E.; Crossley, R.; Curran, A. C. W.; Hill, D. G.; Lawrence, A. E. J. Med.
Chem. 1977, 20, 718.(d) Robison, M. M.; Robison, B. L.; Butler, F. P. J.
Am. Chem. Soc. 1959, 81, 743.
(10) Marminon, C.; Pierre´, A.; Pfeiffer, B.; Pe´rez, V.; Le´once, S.; Renard,
P.; Prudhomme, M. Bioorg. Med. Chem. 2003, 11, 679 and references
therein.
Finally, we examined the possibility of constructing a
pyridine fused to a seven-membered ring. Derivatives of
tetrahydro-5H-pyrido[2,3-b]azepin-8-ones are very rare,20 and
a simple, efficient route to such structures would significantly
(11) Viswanathan, R.; Mutnick, D.; Johnston, J. N. J. Am. Chem. Soc.
2003, 125, 7266.
(12) Davies, A. J.; Brands, K. M. J.; Cowden, C. J.; Dolling, U.-H.;
Lieberman, D. R. Tetrahedron Lett. 2004, 45, 1721 and references therein.
(13) Kunieda, T.; Higuchi, T.; Abe, Y.; Hirobe, M. Tetrahedron 1983,
39, 3253.
(14) Hantzsch, S. Justus Liebigs Ann. Chem. 1889, 250, 269. For a recent
pharmaceutical use of thiazoles, see: Cosford, N. D. P.; Tehrani, L.; Roppe,
J.; Schweiger, E.; Smith, N. D.; Anderson, J.; Bristow, L.; Brodkin, J.;
Jiang, X.; McDonald, I.; Rao, S.; Washburn, M.; Varney, M. A. J. Med.
Chem. 2003, 46, 204.
(16) For a recent pharmaceutical use of this class of compounds, see:
Hutchinson, J. H.; Halczenko, W.; Brashear, K. M.; Breslin, M. J.; Coleman,
P. J.; Duong, L. T.; Fernandez-Metzler, C.; Gentile, M. A.; Fisher, J. E.;
Hartman, G. D.; Huff, J. R.; Kimmel, D. B.; Leu, C. T.; Meissner, R. S.;
Merkle, K.; Nagy, R.; Pennypacker, B.; Perkins, J. J.; Prueksaritanont, T.;
Rodan, G. A.; Varga, S. L.; Wesolowski, G. A.; Zartman, A. E.; Rodan, S.
B.; Duggan, M. E. J. Med. Chem. 2003, 46, 4790.
(17) For a recent review on the Skraup reaction, see: Hamada, Y.;
Takeuchi, I. Yakugaku Zasshi 2000, 120, 206.
(18) For a review on the Friedla¨nder reaction, see: Cheng, C.-C.; Yan,
S. J. Org. React. 1982, 28, 37.
(15) Bergeot, O.; Corsi, C.; El Qacemi, M.; Zard, S. Z. Unpublished
results.
(19) Palucki, M.; Hughes, D. L.; Yasuda, N.; Yang, C.; Reider, P. J.
Tetrahedron Lett. 2001, 42, 6811.
Org. Lett., Vol. 6, No. 21, 2004
3673